These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10713562)

  • 1. In vitro model for frontal sinus obliteration with bioactive glass S53P4.
    Peltola MJ; Suonpää JT; Andersson H; Määttänen HS; Aitasalo KM; Yli-Urpo A; Laippala PJ
    J Biomed Mater Res; 2000; 53(2):161-6. PubMed ID: 10713562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical follow-up method for frontal sinus obliteration with bioactive glass S53P4.
    Peltola MJ; Suonpää JT; Määttänen HS; Varpula MJ; Aitasalo KM; Yli-Urpo A; Laippala PJ
    J Biomed Mater Res; 2001; 58(1):54-60. PubMed ID: 11152998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental follow-up model for clinical frontal sinus obliteration with bioactive glass (S53P4).
    Peltola M; Suonpää J; Aitasalo K; Määttänen H; Andersson O; Yli-Urpo A; Laippala P
    Acta Otolaryngol Suppl; 2000; 543():167-9. PubMed ID: 10909011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo model for frontal sinus and calvarial bone defect obliteration with bioactive glass S53P4 and hydroxyapatite.
    Peltola MJ; Aitasalo KM; Suonpää JT; Yli-Urpo A; Laippala PJ
    J Biomed Mater Res; 2001 May; 58(3):261-9. PubMed ID: 11319739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience.
    Peltola M; Aitasalo K; Suonpää J; Varpula M; Yli-Urpo A
    Head Neck; 2006 Sep; 28(9):834-41. PubMed ID: 16823870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obliteration of the frontal sinus cavity with bioactive glass.
    Peltola M; Suonpää J; Aitasalo K; Varpula M; Yli-Urpo A; Happonen RP
    Head Neck; 1998 Jul; 20(4):315-9. PubMed ID: 9588704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term microscopic and tissue analytical findings for 2 frontal sinus obliteration materials.
    Peltola MJ; Aitasalo KM; Aho AJ; Tirri T; Suonpää JT
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1699-707. PubMed ID: 18634960
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of pre-treatment of crystallized bioactive glass with cell culture media on structure, degradability, and biocompatibility.
    Thavornyutikarn B; Feltis B; Wright PFA; Turney TW
    Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():188-197. PubMed ID: 30678903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro surface reaction layer formation and dissolution of calcium phosphate cement-bioactive glass composites.
    Liu C; Chen CW; Ducheyne P
    Biomed Mater; 2008 Sep; 3(3):034111. PubMed ID: 18689928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frontal sinus and skull bone defect obliteration with three synthetic bioactive materials. A comparative study.
    Peltola MJ; Aitasalo KM; Suonpää JT; Yli-Urpo A; Laippala PJ; Forsback AP
    J Biomed Mater Res B Appl Biomater; 2003 Jul; 66(1):364-72. PubMed ID: 12808596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium phosphate formation at the surface of bioactive glass in vitro.
    Andersson OH; Kangasniemi I
    J Biomed Mater Res; 1991 Aug; 25(8):1019-30. PubMed ID: 1918106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resorption of the calcium phosphate layer on S53P4 bioactive glass by osteoclasts.
    van Gestel NAP; Schuiringa GH; Hennissen JHPH; Delsing ACA; Ito K; van Rietbergen B; Arts JJ; Hofmann S
    J Mater Sci Mater Med; 2019 Aug; 30(8):94. PubMed ID: 31414232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of in vitro modeling conditions on the surface reactions of bioactive glass.
    Radin S; Ducheyne P; Rothman B; Conti A
    J Biomed Mater Res; 1997 Dec; 37(3):363-75. PubMed ID: 9368141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIS buffer in simulated body fluid distorts the assessment of glass-ceramic scaffold bioactivity.
    Rohanová D; Boccaccini AR; Yunos DM; Horkavcová D; Březovská I; Helebrant A
    Acta Biomater; 2011 Jun; 7(6):2623-30. PubMed ID: 21345388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro response of human osteoblasts to multi-step sol-gel derived bioactive glass nanoparticles for bone tissue engineering.
    Fan JP; Kalia P; Di Silvio L; Huang J
    Mater Sci Eng C Mater Biol Appl; 2014 Mar; 36():206-14. PubMed ID: 24433905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histomorphometric and molecular biologic comparison of bioactive glass granules and autogenous bone grafts in augmentation of bone defect healing.
    Virolainen P; Heikkilä J; Yli-Urpo A; Vuorio E; Aro HT
    J Biomed Mater Res; 1997 Apr; 35(1):9-17. PubMed ID: 9104694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro Ca-P precipitation on biodegradable thermoplastic composite of poly(epsilon-caprolactone-co-DL-lactide) and bioactive glass (S53P4).
    Jaakkola T; Rich J; Tirri T; Närhi T; Jokinen M; Seppälä J; Yli-Urpo A
    Biomaterials; 2004 Feb; 25(4):575-81. PubMed ID: 14607495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the frontal intersinus septal cell to widen the narrow frontal recess.
    Chiu AG; Vaughan WC
    Laryngoscope; 2004 Jul; 114(7):1315-7. PubMed ID: 15235368
    [No Abstract]   [Full Text] [Related]  

  • 19. Supraorbital ethmoid cell.
    Owen RG; Kuhn FA
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):254-61. PubMed ID: 9051076
    [No Abstract]   [Full Text] [Related]  

  • 20. Computer-assisted frontal sinusotomy.
    Carrau RL; Snyderman CH; Curtin HB; Weissman JL
    Otolaryngol Head Neck Surg; 1994 Dec; 111(6):727-32. PubMed ID: 7991251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.